3 September 2018 Blog Post: New Research in August on "Baby" Aspirin

In the past when patients have asked me about the role of a daily low dose or “baby” (81mg) aspirin in preventing a first heart attack or stroke, I have referred to it as “my desert island drug.” To illustrate its relative usefulness, I have gone on to say, “if you are on a desert island, and wanted to take one drug, then it could be a baby aspirin. Sufficient to reduce your risk of heart attack and stroke and at a low enough dose that if you fall out of a coconut tree, then you won’t bleed.”
 
The largest randomized, controlled clinical trial of its kind was undertaken to evaluate utility of daily aspirin in preventing a first cardiovascular event (i.e. fatal cardiovascular event, non-fatal heart attack, unstable cardiac rhythm or TIA/stroke) among more than 12,500 participants considered to be at moderate cardiovascular risk. Participants were randomly allocated to receive a 100 mg enteric-coated aspirin tablet daily or placebo. The were followed for, on average, 60 months. The study was sponsored by Bayer.

When considering all cardiovascular events combined, a daily aspirin showed no significant effect. The primary endpoint occurred in 269 (4.29%) individuals in the aspirin group versus 281 (4.48%) in the placebo group.

Of interest, aspirin did reduce the risk of total and nonfatal heart attacks. Aspirin accounted for an 82.1% reduction in these events for those aged 50-59 years of age and and a 54.3% reduction in the 59-69 age group. There was no effect of aspirin use on risk of stroke.

Bleeding was relatively infrequent, and when it occurred, was mild and most commonly from the GI tract – 61 (0.97%) individuals in the aspirin group versus 29 (0.46%) in the placebo group. Other commonly reported side effects of aspirin were indigestion, nosebleeds, gastroesophageal reflux disease, and upper abdominal pain.

So it looks as if I will need to amend my “desert island” advice to exclude any risk reduction in stroke. And 1% of you may get a GI or nose bleed falling out of the coconut tree…

In an equally fascinating study published earlier in the month, Canadian researchers suggested that a low dose daily aspirin could reduce HIV susceptibility. So the aspirin story continues on – a century after becoming available.

𝗦𝗶𝗴𝗻 𝗨𝗽 𝗳𝗼𝗿 𝗢𝘂𝗿 𝗡𝗲𝘄𝘀𝗹𝗲𝘁𝘁𝗲𝗿

Dig deeper into the health topics you care about most by signing up for our newsletter.

by submitting this form you indicate you have
read and agree to our Privacy Policy and Terms
of Use. Please contact us to for us for more
information.

Recommended Posts

No comment yet, add your voice below!


Add a Comment

Your email address will not be published.